"Furthermore, patients with RLS who were not treated with dopamine agonists tended to be at increased risk of developing ...

William “Matt” Howe and Read Montague are senior authors of a study published in Nature Communications that identified a neurochemical signature distinguishing Parkinson’s disease from essential ...

A new study published in Brain Sciences provides evidence that dopamine promotes movement by directly altering the excitability of key neurons in the brain’s motor circuitry. The research identifies a ...

A new study of over 9,900 people with restless leg syndrome (RLS) has suggested that the condition appears to increase the risk of developing Parkinson’s disease (PD). RLS is a neurological condition ...

Overactivation of dopamine neurons may directly drive their death, explaining why movement-controlling brain cells degenerate in Parkinson’s. Mice with chronically stimulated neurons showed the same ...

The study claims to be the first in the world to combine AI and optogenetics in Parkinson’s diagnosis and treatment.

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

For decades, medical understanding of Parkinson’s disease focused exclusively on the brain, specifically the death of dopamine-producing neurons that control movement. This narrow view shaped ...

A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects. The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness, coordination, ...

Long before it had a name, signs of Parkinson’s disease appeared in ancient medical texts. These historical accounts described individuals who experienced tremors and difficulty moving, although it ...